Sunshine Heart Announces Conditional Approval of IDE From the FDA for C-Pulse Heart Assist System

Sunshine Heart, a global medical device company focused on innovative technologies for moderate to severe heart failure, announced it has received conditional approval from the FDA for an investigational device exemption (IDE) for its flagship C-Pulse Heart Assist System.
Equities